|
US3975399A
(en)
|
1974-08-06 |
1976-08-17 |
E. I. Du Pont De Nemours And Company |
1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
|
|
ZA747723B
(en)
*
|
1974-12-11 |
1976-11-24 |
Pfizer |
11-desoxy-15-substituted-omega-pentanor prostaglandins
|
|
US4154949A
(en)
|
1974-12-11 |
1979-05-15 |
Pfizer Inc. |
11-Desoxy-15-substituted-ω-pentanor prostaglandins
|
|
IT1037126B
(it)
*
|
1975-03-14 |
1979-11-10 |
Erba Carlo Spa |
13.4 deidro ii desossi prosta glandine
|
|
DE2517771A1
(de)
|
1975-04-18 |
1976-10-28 |
Schering Ag |
Neue prostaglandin-acetylen-analoga und verfahren zu ihrer herstellung
|
|
DE2528664A1
(de)
|
1975-06-27 |
1977-01-13 |
Hoechst Ag |
Pyrrolidone und verfahren zu ihrer herstellung
|
|
CA1085859A
(en)
|
1975-06-27 |
1980-09-16 |
Wilhelm Bartmann |
Pyrrolidones and process for their manufacture
|
|
DE2619638A1
(de)
|
1976-05-04 |
1977-11-17 |
Hoechst Ag |
Pyrrolidone und verfahren zu ihrer herstellung
|
|
US4268522A
(en)
|
1976-06-14 |
1981-05-19 |
Pfizer Inc. |
13,14-Dihydro-15-alkenyl- and 13,14-dihydro-15-alkynyl prostaglandins and analogs thereof
|
|
US4177346A
(en)
|
1976-08-06 |
1979-12-04 |
Pfizer Inc. |
1,5-Disubstituted-2-pyrrolidones
|
|
DE2729960A1
(de)
*
|
1977-06-30 |
1979-01-18 |
Schering Ag |
Neue acetylenprostaglandine und verfahren zu ihrer herstellung
|
|
US4320136A
(en)
|
1980-08-11 |
1982-03-16 |
E. I. Du Pont De Nemours And Company |
8-Aza-16,16-difluoroprostanoids
|
|
JPS58124778A
(ja)
|
1982-01-20 |
1983-07-25 |
Toray Ind Inc |
５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
|
|
US4456613A
(en)
|
1982-12-27 |
1984-06-26 |
E. I. Du Pont De Nemours And Company |
6-Keto- and 6-hydroxy-8-azaprostanoids and anti-ulcer use thereof
|
|
GB8329559D0
(en)
*
|
1983-11-04 |
1983-12-07 |
Erba Farmitalia |
Furyl derivatives of 16-substituted prostaglandins preparations
|
|
JPH0662599B2
(ja)
|
1987-10-16 |
1994-08-17 |
東レ株式会社 |
２，５，６，７―テトラノル―４，８―インタ―ｍ―フェニレンＰＧＩ２誘導体ならびにその製造法および用途
|
|
WO1989003387A1
(fr)
|
1987-10-16 |
1989-04-20 |
Toray Industries, Inc. |
DERIVES DE 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLENE-PGI2, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION
|
|
DE3835162A1
(de)
*
|
1988-10-13 |
1990-04-19 |
Schering Ag |
(1s,2s,3r,5r)-2-((3s)-2-halogen-3-hydroxy-1-alken(inyl))-3-trialkylsilyloxy-7,7-(2,2-dimethyl-trimethylendioxy)-bicyclo-(3.3.0)-octan-verbindungen und verfahren zu deren herstellung
|
|
US7229959B1
(en)
|
1990-11-27 |
2007-06-12 |
The American National Red Cross |
Supplemented fibrin matrix delivery systems
|
|
CA2093836A1
(en)
|
1992-04-24 |
1993-10-25 |
Wayne Gombotz |
Biodegradable tgf-.beta. delivery system for bone regeneration
|
|
JP3388867B2
(ja)
|
1994-03-31 |
2003-03-24 |
株式会社東芝 |
宛名領域検出装置および宛名領域検出方法
|
|
AU1120295A
(en)
|
1994-11-07 |
1996-05-31 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Cartilage-derived morphogenetic proteins
|
|
US7517539B1
(en)
|
1996-10-16 |
2009-04-14 |
Etex Corporation |
Method of preparing a poorly crystalline calcium phosphate and methods of its use
|
|
US20020098222A1
(en)
|
1997-03-13 |
2002-07-25 |
John F. Wironen |
Bone paste
|
|
ZA984040B
(en)
|
1997-05-15 |
1998-11-20 |
Ono Pharmaceutical Co |
Benzenesulfonamide compounds
|
|
US6043275A
(en)
|
1998-04-16 |
2000-03-28 |
Ono Pharmaceutical Co., Ltd. |
3,7-dithiaprostanoic acid derivative
|
|
TWI249520B
(en)
|
1998-07-15 |
2006-02-21 |
Ono Pharmaceutical Co |
5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient
|
|
US6894175B1
(en)
|
1999-08-04 |
2005-05-17 |
The Procter & Gamble Company |
2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
|
|
TWI247606B
(en)
|
1999-11-24 |
2006-01-21 |
Ono Pharmaceutical Co |
Treating agent for osteopenic diseases
|
|
AP2001002357A0
(en)
|
1999-12-22 |
2001-12-31 |
Pfizer Prod Inc |
EP4 receptor selective agonists in the treatment of osteoporosis.
|
|
US20010056060A1
(en)
|
2000-02-07 |
2001-12-27 |
Cameron Kimberly O. |
Treatment of osteoporsis with EP2/EP4 receptor selective agonists
|
|
WO2002024647A1
(en)
|
2000-09-21 |
2002-03-28 |
Ono Pharmaceutical Co., Ltd. |
Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
|
|
PT1339678E
(pt)
*
|
2000-11-27 |
2007-11-30 |
Pfizer Prod Inc |
Agonistas selectivos do receptor ep4 no tratamento de osteoporose
|
|
TWI267378B
(en)
|
2001-06-08 |
2006-12-01 |
Wyeth Corp |
Calcium phosphate delivery vehicles for osteoinductive proteins
|
|
ES2254726T3
(es)
|
2001-07-16 |
2006-06-16 |
F. Hoffmann-La Roche Ag |
Analogos de prostaglandina como agonistas receptores de ep4.
|
|
CN1863768A
(zh)
*
|
2001-07-16 |
2006-11-15 |
霍夫曼-拉罗奇有限公司 |
作为ep4受体激动剂的前列腺素类似物
|
|
RU2296122C2
(ru)
|
2001-07-16 |
2007-03-27 |
Ф.Хоффманн-Ля Рош Аг |
Производные 2-пирролидона в качестве простаноидных агонистов и фармацевтическая композиция
|
|
NZ530885A
(en)
|
2001-07-23 |
2007-09-28 |
Ono Pharmaceutical Co |
Remedies for diseases with bone mass loss having EP4 agonist as the active ingredient
|
|
JP4550417B2
(ja)
|
2001-10-23 |
2010-09-22 |
メルク セローノ ソシエテ アノニム |
プロスタグランジンｅｐ２及び／又はｅｐ４受容体のリガンドとしてのポリアゾリジノン化合物
|
|
US20040204590A1
(en)
|
2001-12-03 |
2004-10-14 |
Ogidigben Miller J. |
Ep4 receptor agonist, compositions and methods thereof
|
|
CA2466757A1
(en)
*
|
2001-12-03 |
2003-06-12 |
Merck & Co., Inc. |
Method for treating ocular hypertension
|
|
AU2003211574A1
(en)
|
2002-03-05 |
2003-09-16 |
Ono Pharmaceutical Co., Ltd. |
8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
|
|
BR0308493A
(pt)
|
2002-03-18 |
2005-01-11 |
Pfizer Prod Inc |
Uso de agonistas de receptor seletivo de ep4 para o tratamento da insuficiência hepática, perda de permeabilidade do canal arterial, glaucoma ou hipertensão ocular
|
|
CA2478653A1
(en)
|
2002-03-18 |
2003-09-25 |
Pfizer Products Inc. |
Methods of treatment with selective ep4 receptor agonists
|
|
US7326426B2
(en)
|
2002-03-29 |
2008-02-05 |
Ethicon, Inc. |
Compositions and medical devices utilizing bioabsorbable liquid polymers
|
|
US6573294B1
(en)
|
2002-05-14 |
2003-06-03 |
Allergan, Inc. |
8-azaprostaglandin analogs as agents for lowering intraocular pressure
|
|
DE60334905D1
(de)
|
2002-06-06 |
2010-12-23 |
Merck Frosst Canada Ltd |
1,5-disubstituierte pyrrolid-2-on-derivate zur verwendung als ep4 rezeptor agonisten zur behandlung von augenkrankheiten wie z.b. glaukom
|
|
US7419999B2
(en)
|
2002-06-10 |
2008-09-02 |
Applied Research Systems Ars Holding N.V. |
Gamma lactams as prostaglandin agonists and use thereof
|
|
AU2003275840A1
(en)
|
2002-10-25 |
2004-05-13 |
Merck Frosst Canada Ltd |
2-pyrrolidones as EP4 receptor agonists
|
|
US7256211B1
(en)
|
2003-01-21 |
2007-08-14 |
Ono Pharmaceutical Co., Ltd. |
8-azaprostaglandin derivatives and medical use thereof
|
|
ATE394372T1
(de)
|
2003-03-03 |
2008-05-15 |
Serono Lab |
G-lactamderivate als prostaglandinagonisten
|
|
US7163920B2
(en)
|
2003-09-30 |
2007-01-16 |
Ethicon, Inc. |
Peptide with osteogenic activity
|
|
US20070191319A1
(en)
|
2003-12-17 |
2007-08-16 |
Pfizer Inc. |
Treatment of conditions that present with low bone mass by continuous combination therapy with selective prostaglandin ep4 receptor agonists and an estrogen
|
|
US7169807B2
(en)
|
2004-04-09 |
2007-01-30 |
Allergan, Inc. |
10-Hydroxy-11-dihydroprostaglandin analogs as selective EP4 agonists
|
|
EP1782830A4
(en)
|
2004-08-10 |
2009-07-29 |
Ono Pharmaceutical Co |
PREVENTION AND / OR REMEDY FOR LOWER URINARY TRACT DISEASES CONTAINING AN EP4 AGONIST
|
|
US20080234337A1
(en)
|
2004-08-10 |
2008-09-25 |
Ono Pharmaceutical Co., Ltd. |
Preventive and/or Remedy for Hyperkalemia Containing Ep4 Agonist
|
|
US20060039949A1
(en)
|
2004-08-20 |
2006-02-23 |
Nycz Jeffrey H |
Acetabular cup with controlled release of an osteoinductive formulation
|
|
US20060057184A1
(en)
|
2004-09-16 |
2006-03-16 |
Nycz Jeffrey H |
Process to treat avascular necrosis (AVN) with osteoinductive materials
|
|
US7621963B2
(en)
|
2005-04-13 |
2009-11-24 |
Ebi, Llc |
Composite bone graft material
|
|
BRPI0610469A2
(pt)
|
2005-05-27 |
2012-10-23 |
Royer Biomedical Inc |
composição bioerodìvel para a administração de um agente bioativo, kit para a formação de uma composição bioerodìvel, métodos de produção de uma composição bioerodìvel solidificada para a administração de um agente bioativo, de produção de uma fibra bioerodìvel para a administração de um agente bioativo e de formação de um filme bioerodìvel para a administração de um agente bioativo, dispositivo médico implantável, e, método de administração de um agente bioativo para um local do corpo necessitando do mesmo
|
|
CN103349793B
(zh)
|
2005-09-09 |
2016-02-10 |
阿格诺沃斯健康关爱公司 |
复合骨移植替代物水泥以及由其制得的制品
|
|
KR20060013354A
(ko)
|
2005-12-09 |
2006-02-09 |
(주)코리아 본 뱅크 |
인산칼슘계 시멘트 첨가에 의해 개질된 탈회골 기질의 개발
|
|
US20070232660A1
(en)
|
2006-04-04 |
2007-10-04 |
Allergan, Inc. |
Therapeutic and delivery methods of prostaglandin ep4 agonists
|
|
AU2008246579A1
(en)
|
2007-05-08 |
2008-11-13 |
National University Corporation, Hamamatsu University School Of Medicine |
Cytotoxic T cell activator comprising EP4 agonist
|
|
US8088793B2
(en)
|
2007-08-15 |
2012-01-03 |
Cytokinetics, Inc. |
Certain chemical entities, compositions, and methods
|
|
KR20100086485A
(ko)
|
2007-10-23 |
2010-07-30 |
알러간, 인코포레이티드 |
치료적 치환된 락탐
|
|
US20090112332A1
(en)
|
2007-10-31 |
2009-04-30 |
Alexis Paul Shelokov |
Bone graft and bone graft substitutes with antibiotics for sustained, localized release of antibiotics for reducing postoperative surgical wound infection in spinal and other bone surgery
|
|
WO2011127149A1
(en)
|
2010-04-06 |
2011-10-13 |
University Of Utah Research Foundation |
Controlled release combination biomaterials
|
|
US8685432B2
(en)
|
2008-03-25 |
2014-04-01 |
University Of Utah Research Foundation |
Controlled release tissue graft combination biomaterials
|
|
WO2009129316A2
(en)
|
2008-04-15 |
2009-10-22 |
Etex Corporation |
Minimally invasive treatment of vertebra (mitv) using a calcium phosphate combination bone cement
|
|
WO2010011599A2
(en)
|
2008-07-22 |
2010-01-28 |
Osteogenex Inc. |
Pimethixene derivatives for promoting bone growth
|
|
WO2010025135A2
(en)
|
2008-08-28 |
2010-03-04 |
Osteogenex Inc. |
Trimeprazine and ethopropazine derivatives for promoting bone growth
|
|
US9320761B2
(en)
|
2008-12-18 |
2016-04-26 |
Vivex Biomedical, Inc. |
Bone induction system and methods
|
|
US20120270934A1
(en)
|
2009-07-03 |
2012-10-25 |
Concert Pharmaceuticals, Inc. |
Prostacyclin derivatives
|
|
US9107983B2
(en)
|
2010-10-27 |
2015-08-18 |
Warsaw Orthopedic, Inc. |
Osteoconductive matrices comprising statins
|
|
CA2815179A1
(en)
*
|
2010-11-10 |
2012-05-18 |
Actelion Pharmaceuticals Ltd |
Lactam derivatives useful as orexin receptor antagonists
|
|
US8613938B2
(en)
|
2010-11-15 |
2013-12-24 |
Zimmer Orthobiologics, Inc. |
Bone void fillers
|
|
US20120283293A1
(en)
|
2011-05-06 |
2012-11-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of neuroprotection involving Prostaglandin E2 EP4 (PGE2 EP4) receptor activation
|
|
JP6052175B2
(ja)
|
2011-08-02 |
2016-12-27 |
小野薬品工業株式会社 |
左室拡張機能改善剤
|
|
CN107802623B
(zh)
|
2012-07-19 |
2020-10-30 |
开曼化学股份有限公司 |
用于ep4介导的骨相关疾病和病症的二氟内酰胺组合物
|
|
US20170260173A1
(en)
|
2012-07-19 |
2017-09-14 |
Myometrics, Llc |
Difluorolactam compositions for ep4-mediated osteo related diseases and condtions
|
|
JP6368351B2
(ja)
|
2013-03-15 |
2018-08-01 |
ケイマン ケミカル カンパニー， インコーポレーテッド |
ジフルオロラクタムアナログを合成する方法
|
|
WO2014144610A1
(en)
|
2013-03-15 |
2014-09-18 |
Cayman Chemical Company, Inc. |
Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
|
|
EP3235817B1
(en)
|
2013-03-15 |
2018-12-12 |
Cayman Chemical Company, Incorporated |
Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
|
|
JP2016527006A
(ja)
|
2013-07-19 |
2016-09-08 |
ケイマン ケミカル カンパニー， インコーポレーテッド |
骨成長を促進するための方法、システム、及び組成物
|
|
WO2017022045A1
(ja)
|
2015-08-03 |
2017-02-09 |
株式会社ｓｉｚｅｂｏｏｋ |
携帯情報装置、寸法測定方法、および寸法測定プログラム
|